Frontotemporal dementia (FTD) is considered to have a heterogeneous aetiolo
gy. To date the tau gene located on chromosome 17 has been shown to be impl
icated in the pathogenesis of several FTD families with parkinsonism, the s
o called FTDP-17 families. The mutations reported so far are located within
exons 9 to 13, a region coding for the microtubule-binding sites. They are
causing various cytoskeletal disturbances. We are describing here the main
clinical and neuropathological features of a Swiss FTD family with members
presenting a FTDP-like clinical phenotype. However, if we except two silen
t polymorphic sites at position 227 and 255 in exon 9, neither a known FTDP
-17 mutation nor a novel one was detected in this region of the tau gene. T
hus, the existence of a yet unknown mechanism of neurodegeneration, other t
han via mutations near or within the microtubule-binding sites, or the exon
10 splice sites of the tau gene, has to be considered to explain dementia
in this family. A mutation in another gene is still possible. (C) 2000 Acad
emic Press.